Mitral annular remodeling to treat functional mitral regurgitation: A pilot acute study in a canine model

Heart Surgery Forum

Volumn 13, Issue 4, 2010, Pages

  Fumoto, Hideyuki ^a   Takaseya, Tohru ^a   Shiose, Akira ^a   Saraiva, Roberto M ^a   Arakawa, Yoko ^a   Park, Margaret ^a   Rao, Santosh ^a   Dessoffy, Raymond ^a   Chen, Ji Feng ^a   Zhou, Qun ^a   Calabro Jr , Anthony ^a   Banbury, Michael ^b   Fukamachi, Kiyotaka ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CHRISTIANA CARE HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; TYRAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOG; ECHOCARDIOGRAPHY; FUNCTIONAL ASSESSMENT; HEART MUSCLE ISCHEMIA; HEART PAPILLARY MUSCLE; HEMODYNAMICS; HYDROGEL; MITRAL VALVE REGURGITATION; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL;

ANIMALS; DOGS; ECHOCARDIOGRAPHY; FEASIBILITY STUDIES; HEART VENTRICLES; HYALURONIC ACID; HYDROGEL; INJECTIONS, INTRAMUSCULAR; MITRAL VALVE INSUFFICIENCY; PAPILLARY MUSCLES; PILOT PROJECTS; POSTOPERATIVE PERIOD; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77956626866     PISSN: 10983511     EISSN: 15226662     Source Type: Journal    
DOI: 10.1532/HSF98.20101003     Document Type: Article

References (11)

1. Byrne MJ, Kaye DM, Mathis M, Reuter DG, Alferness CA, Power JM. 2004. Percutaneous mitral annular reduction provides continued benefit in an ovine model of dilated cardiomyopathy. Circulation 110:3088-92.
2. Darr A, Calabro A. 2009. Synthesis and characterization of tyramine-based hyaluronan hydrogels. J Mater Sci Mater Med 20:33-44.
3. Grossi EA, Woo YJ, Schwartz CF, et al. 2006. Comparison of Coapsys annuloplasty and internal reduction mitral annuloplasty in the randomized treatment of functional ischemic mitral regurgitation: impact on the left ventricle. J Thorac Cardiovasc Surg 131:1095-8.
4. Herrmann HC, Rohatgi S, Wasserman HS, et al. 2006. Mitral valve hemodynamic effects of percutaneous edge-to-edge repair with the MitraClip device for mitral regurgitation. Catheter Cardiovasc Interv 68:821-8.
5. Hung J, Solis J, Guerrero JL, et al. 2008. A novel approach for reducing ischemic mitral regurgitation by injection of a polymer to reverse remodel and reposition displaced papillary muscles. Circulation 118(suppl):S263-9.
6. [ILAR] Institute of Laboratory Animal Research, Commission on Life Sciences, National Research Council. 1996. Guide for the care and use of laboratory animals. Washington, DC: National Academies Press.
7. Inoue M, McCarthy PM, Popovic ZB, et al. 2004. The Coapsys device to treat functional mitral regurgitation: in vivo long-term canine study. J Thorac Cardiovasc Surg 127:1068-76; discussion 1076-7.
8. Kamohara K, Banbury M, Calabro A, et al. 2006. A novel technique for functional mitral regurgitation therapy: mitral annular remodeling. Heart Surg Forum 9:E888-92.
9. Kuwahara E, Otsuji Y, Iguro Y, et al. 2006. Mechanism of recurrent/ persistent ischemic/functional mitral regurgitation in the chronic phase after surgical annuloplasty: importance of augmented posterior leaflet tethering. Circulation 114:I529-34.
10. Maniu CV, Patel JB, Reuter DG, et al. 2004. Acute and chronic reduction of functional mitral regurgitation in experimental heart failure by percutaneous mitral annuloplasty. J Am Coll Cardiol 44:1652-61.
11. McGee EC, Gillinov AM, Blackstone EH, et al. 2004. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg 128:916-24.